Publication

Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP

Abdulwahid, D.
; 
Arbuthnot, C.
; 
Paneesha, S.
; 
Jobanputra, S.
; 
Borg, A.
Abstract
Poster abstract 198 in the section 'Lymphoid Malignancy – Clinical' of the XXXVI World Congress of the International Society of Hematology, hosted by the British Society for Haematology, 18–21 April 2016, Glasgow, UK.
MIDER Authors
Arbuthnot, C.
Borg, A.
Citations
Altmetric:
Date
2016-04-12
Type
Conference Output
Subject
Haematology, Oncology. Pathology.
Collections
SWFT Haematology
Patient Information Leaflets
Show all metadata
Citation
Abdulwahid D, Arbuthnot C, Paneesha S, Jobanputra S, Borg A. Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP. Br J Haematol. 2016 Apr;173(Suppl 1):83. doi: 10.1111/bjh.14019.
Journal / Source Title
British Journal of Haematology
DOI
10.1111/bjh.14019
URI
http://hdl.handle.net/20.500.14200/7595
PMID
27073127
Publisher
Wiley
Publisher’s URL
Publisher’s statement
Note / Copyright